(152 days)
No
The 510(k) summary describes a physical implant (PEEK cage with a titanium coating) used for cervical fusion. There is no mention of software, algorithms, or any technology that would typically incorporate AI/ML. The testing described is focused on the mechanical and material properties of the implant.
Yes
The device is described as a Cervical Fusion System indicated for cervical interbody fusion procedures to treat cervical disc disease, which involves addressing a medical condition (intractable radiculopathy and/or myelopathy) and restoring function.
No
This device is an implantable medical device (cervical fusion system) used for treatment, specifically for cervical interbody fusion procedures. It is not designed to diagnose a condition, but rather to treat it. The "radiographic studies" mentioned refer to the method of confirming the patient's condition, not a function of the device itself.
No
The device description clearly states it consists of "PEEK cages of various widths and heights" and mentions "commercially pure titanium (CP Ti) coating," indicating it is a physical implant, not software. The performance studies also focus on the mechanical properties and testing of the physical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use describes a surgical implant for cervical interbody fusion. This is a therapeutic device, not a diagnostic one.
- Device Description: The device is a PEEK cage with a titanium coating, designed to provide structural support during surgery. This is a physical implant, not a reagent or instrument used to examine specimens from the human body.
- Lack of Diagnostic Function: The description does not mention any function related to diagnosing a disease or condition by analyzing samples (blood, tissue, etc.).
- Input Imaging Modality: While radiographic studies are mentioned, they are used to confirm the condition and guide the surgical procedure, not as the primary input for the device itself to perform a diagnostic test.
- Performance Studies: The performance studies focus on the mechanical properties and biocompatibility of the implant, which are relevant for a surgical device, not a diagnostic one.
IVD devices are used to perform tests on specimens taken from the human body to provide information for diagnosis, monitoring, or screening. This device is a surgical implant used in the body for treatment.
N/A
Intended Use / Indications for Use
The ANATOMIC PEEK PTC Cervical Fusion System is indicated for cervical interbody fusion procedures in skeletally mature patients with cervical disc disease at one level from the C2-C3 disc to the C7-T1 disc. Cervical disc disease is defined as intractable radiculopathy and/or myelopathy with herniated disc and/or osteophyte formation on posterior vertebral endplates producing symptomatic nerve root and/or spinal cord compression confirmed by radiographic studies. This device is to be used in patients who have had six weeks of non-operative treatment. The ANATOMIC PEEK PTC device is to be used with supplemental fixation. The ANATOMIC PEEK PTC Cervical Fusion System is also required to be used with autogenous bone graft and/or allogenic bone graft comprised of cancellous and/or corticocancellous bone graft, and is to be implanted via an open anterior approach.
Product codes (comma separated list FDA assigned to the subject device)
ODP
Device Description
The ANATOMIC PEEK PTC Cervical Fusion System consists of PEEK cages of various widths and heights, which can be inserted between two cervical discs to give support and correction during cervical interbody fusion surgeries. The hollow geometry of the implants allows them to be packed with autogenous bone graft and/or allogenic bone graft comprised of cancellous and/or corticocancellous bone.
The ANATOMIC PEEK PTC Cervical Fusion System will be available in all the same sizes as the predicate system.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Cervical spine, C2-C3 disc to C7-T1 disc
Indicated Patient Age Range
Skeletally mature patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Testing:
- Testing of the CP Ti coating, which is plasma sprayed, was performed according to FDA's Guidance for FDA Reviewers/Staff, "Guidance for Industry on the Testing of Metallic Plasma Sprayed Coatings on Orthopedic Implants to Support Reconsideration of Postmarket Surveillance Requirements," issued February 2, 2000.
- Coating Microstructure: ASTM F1854, Standard test method for stereological evaluation of porous coatings on medical implants
- Shear Fatigue Testing: ASTM F1160, Standard Test Method for Shear and Bending Fatigue Testing of Calcium Phosphate and Metallic Medical and Composite Calcium Phosphate/ Metallic Coatings
- Static Shear Testing: ASTM F1044. Standard test method for shear testing of calcium phosphate coatings and metallic coatings
- Tensile Testing: ASTM F1147, Standard test method for tension testing of calcium phosphate & metallic coatings
- Abrasion Testing: ASTM F1978. Standard Test Method for Measuring Abrasion Resistance of Metallic Thermal Spray Coatings by Using the Taber Abraser
- Mechanical testing was conducted to demonstrate substantial equivalence to the predicate devices:
- Static compression
- Dynamic compression
- Static compression shear
- Dynamic compression shear fatigue
- Torsional fatigue
- Static torsion testing (performed in accordance with ASTM F2077: Test Methods for Intervertebral Body Fusion Devices)
- Subsidence testing (performed in accordance with ASTM F2267: Standard Test Method for Measuring Load Induced Subsidence of the Intervertebral Body Fusion Device under Static Axial Compression)
- Static push-out (expulsion) testing (performed in accordance with ASTM Draft Standard F04.25.02.02. Static Pushout Test Method for Intervertebral Body Fusion Devices)
- Wear particulate testing (performed in accordance with ASTM F1877, Standard Practice for Characterization of Particles)
- Animal testing was also performed using canines and CP Ti coated coupons.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3080 Intervertebral body fusion device.
(a)
Identification. An intervertebral body fusion device is an implanted single or multiple component spinal device made from a variety of materials, including titanium and polymers. The device is inserted into the intervertebral body space of the cervical or lumbosacral spine, and is intended for intervertebral body fusion.(b)
Classification. (1) Class II (special controls) for intervertebral body fusion devices that contain bone grafting material. The special control is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intervertebral Body Fusion Device.” See § 888.1(e) for the availability of this guidance document.(2) Class III (premarket approval) for intervertebral body fusion devices that include any therapeutic biologic (e.g., bone morphogenic protein). Intervertebral body fusion devices that contain any therapeutic biologic require premarket approval.
(c)
Date premarket approval application (PMA) or notice of product development protocol (PDP) is required. Devices described in paragraph (b)(2) of this section shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
0
510(k) Summary
APR 2 8 2014
MEDTRONIC Sofamor Danek ANATOMIC PEEK PTC Cervical Fusion System March 2014
| I. | Company: | Medtronic Sofamor Danek, USA Inc.
1800 Pyramid Place
Memphis, Tennessee 38132
(901) 396-3133 |
|------|-----------------------------------------|---------------------------------------------------------------------------------------------------------|
| II. | Contact: | Julie Bassett
Regulatory Affairs Program Manager
Telephone: (901) 399-3248
Fax: (901) 346-9738 |
| III. | Proposed Proprietary Trade Name: | ANATOMIC PEEK PTC Cervical
Fusion System |
| IV. | Classification Names: | Intervertebral Body Fusion Device
(21 CFR 888.3080) |
| | Class: | II |
| | Product Code: | ODP |
V. Description:
The ANATOMIC PEEK PTC Cervical Fusion System consists of PEEK cages of various widths and heights, which can be inserted between two cervical discs to give support and correction during cervical interbody fusion surgeries. The hollow geometry of the implants allows them to be packed with autogenous bone graft and/or allogenic bone graft comprised of cancellous and/or corticocancellous bone.
The ANATOMIC PEEK PTC Cervical Fusion System will be available in all the same sizes as the predicate system.
1
VI. Indications for Use:
The ANATOMIC PEEK PTC Cervical Fusion System is indicated for cervical interbody fusion procedures in skeletally mature patients with cervical disc disease at one level from the C2-C3 disc to the C7-T1 disc. Cervical disc disease is defined as intractable radiculopathy and/or myelopathy with herniated disc and/or osteophyte formation on posterior vertebral endplates producing symptomatic nerve root and/or spinal cord compression confirmed by radiographic studies. This device is to be used in patients who have had six weeks of non-operative treatment. The ANATOMIC PEEK PTC device is to be used with supplemental fixation. The ANATOMIC PEEK PTC Cervical Fusion System is also required to be used with autogenous bone graft and/or allogenic bone graft comprised of cancellous and/or corticocancellous bone graft, and is to be implanted via an open anterior approach.
VII. Summary of the Technological Characteristics:
The ANATOMIC PEEK PTC Cervical Fusion System has the same fundamental technology as the predicate ANATOMIC PEEK Cervical Fusion System. The ANATOMIC PEEK PTC Cervical Fusion System implants (subject devices) and the ANATOMIC PEEK Cervical Fusion System implants (predicate devices), are both made from PEEK material with tantalum markers. In addition, the predicate and subject devices have the same geometry and are designed to contain graft material and facilitate fusion between two vertebral bodies. The only difference between the subject and predicate devices is the subject devices also have a commercially pure titanium (CP Ti) coating.
2
Identification of Legally Marketed Devices: VIII.
The ANATOMIC PEEK PTC Cervical Fusion System has the same indications for use and fundamental scientific technology as the predicate. ANATOMIC PEEK Cervical Fusion System (K112444. SE 11/15/2011 and K130177, SE 09/23/2013).
An additional predicate, X-Spine's Calix™ PC System (K112036, SE 11/8/2011), is also being used to demonstrate that the titanium coating is not new and currently exists on other legally marketed devices.
IX. Discussion of Non-Clinical Testing:
Testing of the CP Ti coating, which is plasma sprayed, was performed according to FDA's Guidance for FDA Reviewers/Staff, "Guidance for Industry on the Testing of Metallic Plasma Sprayed Coatings on Orthopedic Implants to Support Reconsideration of Postmarket Surveillance Requirements," issued February 2, 2000. The testing was performed according to the applicable ASTM standards listed below:
Coating Microstructure:
- . ASTM F1854, Standard test method for stereological evaluation of porous coatings on medical implants
Shear Fatigue Testing:
- ASTM F1160, Standard Test Method for Shear and Bending Fatigue . Testing of Calcium Phosphate and Metallic Medical and Composite Calcium Phosphate/ Metallic Coatings
Static Shear Testing:
- . ASTM F1044. Standard test method for shear testing of calcium phosphate coatings and metallic coatings
3
Tensile Testing:
- . ASTM F1147, Standard test method for tension testing of calcium phosphate & metallic coatings
Abrasion Testing:
- . ASTM F1978. Standard Test Method for Measuring Abrasion Resistance of Metallic Thermal Spray Coatings by Using the Taber Abraser
In order to demonstrate substantial equivalence to the predicate devices, mechanical testing was conducted. Static compression, dynamic compression, static compression shear, dynamic compression shear fatigue, torsional fatigue, and static torsion testing were performed in accordance with ASTM F2077: Test Methods for Intervertebral Body Fusion Devices. Subsidence testing was performed in accordance with ASTM F2267: Standard Test Method for Measuring Load Induced Subsidence of the Intervertebral Body Fusion Device under Static Axial Compression. Static push-out (expulsion) testing was also performed in accordance with ASTM Draft Standard F04.25.02.02. Static Pushout Test Method for Intervertebral Body Fusion Devices. In addition, wear particulate testing was performed in accordance with ASTM F1877, Standard Practice for Characterization of Particles.
Animal testing was also performed using canines and CP Ti coated coupons.
XI. Conclusion:
Based on the risk analysis, test results, and additional supporting documentation provided in this pre-market notification, Medtronic believes the subject ANATOMIC PEEK PTC Cervical Fusion System is substantially equivalent to the predicate ANATOMIC PEEK Cervical Fusion System.
4
Image /page/4/Picture/0 description: The image shows the logo for the Department of Health & Human Services (HHS). The logo consists of a stylized eagle with three wavy lines extending from its body, representing the department's commitment to health and well-being. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle symbol.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
April 28, 2014
Medtronic Sofamor Danek USA. Incorporated Ms. Julie Bassett Regulatory Affairs Program Manager 1800 Pyramid Place Memphis. Tennessee 38132
Re: K133653
Trade/Device Name: ANATOMIC PEEK PTC Cervical Fusion System Regulation Number: 21 CFR 888.3080 Regulation Name: Intervertebral body fusion device Regulatory Class: Class II Product Code: ODP Dated: March 26. 2014 Received: March 27, 2014
Dear Ms. Bassett:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976. the enactment date of the Medical Device Amendments. or 10 devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into cither class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA s issuance of a substantial equivalence determination does not mean that FDA has made a determination that vour device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
5
Page 2 - Ms. Julie Bassett
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic · product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers. International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/McdicalDevices/Safetv/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
Ronald P. Jean -S for
- Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known)
KI33653
Device Name
ANATOMIC PEEK PTC Cervical Fusion System
Indications for Use (Describe)
The ANATOMIC PEEK PTC Cervical Fusion System is indicated for cervical interbody fision procedures in skeletally mature patients with cervical disc disease at one level from the C7-T1 disc. Cervical disc discase is defined as intractable rodiculorativ and/or myelopality with hermiated disc and/or osterior vertebral endolates producing symptomatic nerve root and or spinal confirmed by maior sudies. This device is to be used in patients who bave had six weeks of non-operative treatment. The ANATOMIC PEEK PTC device is to be used with supplemental fixation. The ANATOMIC PEEK PTC CERVICAL FUSION SYSTEM is also required to be used with autogenous bone graft and/or allogenic bone graft comprised of cancellous and/or corticocancellous bone graft, and is to be implanted via an open anterior approach.
Type of Use (Select one or both, as applicable)
🇿 Prescription Use (Part 21 CFR 801 Subpart D)
[ ] Over-The-Counter Use (21 CFR 801 Subpart C)
Form Approved: OMB No. 0910-0120
Expiration Date: December 31, 2013
See PRA Statement on last page.
PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
nton E. Dmitriev.
NOTICE
This material may be protected by copyright law (Title 17 U.S. Code)
7
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."